{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:24:53Z","timestamp":1790904293346,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,5,28]]},"DOI":"10.18632\/aging.103125","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T16:06:30Z","timestamp":1590681990000},"page":"8953-8967","source":"Crossref","is-referenced-by-count":36,"title":["Valproic acid-labeled chitosan nanoparticles promote recovery of neuronal injury after spinal cord injury"],"prefix":"10.18632","volume":"12","author":[{"given":"Dimin","family":"Wang","sequence":"first","affiliation":[{"name":"School of Medicine, Zhejiang University, Hangzhou, China"},{"name":"College of Basic Medical Sciences, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonglin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/CLEP.S68889","article-title":"Global prevalence and incidence of traumatic spinal cord injury.","volume":"6","author":"Fehlings","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00586-014-3424-6","article-title":"Incidence of traumatic spinal cord injury worldwide: a systematic review.","volume":"2","author":"Rahimi-Movaghar","year":"2015","journal-title":"Eur Spine J"},{"key":"3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000350710","article-title":"Epidemiology of traumatic spinal cord injury in developing countries: a systematic review.","volume":"4","author":"Vaccaro","year":"2013","journal-title":"Neuroepidemiology"},{"key":"4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00109-005-0663-3","article-title":"Molecular targets in spinal cord injury.","volume":"8","author":"Martin-Villalba","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/neu.2008.0523","article-title":"Spinal cord contusion causes acute plasma membrane damage.","volume":"2","author":"LaPlaca","year":"2009","journal-title":"J Neurotrauma"},{"key":"6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","article-title":"Epidemiology, demographics, and pathophysiology of acute spinal cord injury.","volume":"2","author":"Fehlings","journal-title":"Spine"},{"key":"7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00223-014-9947-3","article-title":"Differences in bone mineral density, markers of bone turnover and extracellular matrix and daily life muscular activity among patients with recent motor-incomplete versus motor-complete spinal cord injury.","volume":"9","author":"Iversen","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"8","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1523\/JNEUROSCI.4459-09.2010","article-title":"BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury.","volume":"3","author":"Kessler","year":"2010","journal-title":"J Neurosci"},{"key":"9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jnr.20345","article-title":"Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats.","volume":"7","author":"Singh","year":"2005","journal-title":"J Neurosci Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury.","volume":"3","author":"Ruitenberg","year":"2015","journal-title":"J Neurosci"},{"key":"11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","article-title":"Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system.","volume":"3","author":"Pekny","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2009.11.025","article-title":"Role of GFAP in morphological retention and distribution of reactive astrocytes induced by scrapie encephalopathy in mice.","volume":"131","author":"Itohara","year":"2010","journal-title":"Brain Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1089\/neu.2018.5675","article-title":"Increased levels of circulating GFAP and CRMP2 autoantibodies in the acute stage of spinal cord injury predict the subsequent development of neuropathic pain.","volume":"3","author":"Dash","year":"2018","journal-title":"J Neurotrauma"},{"key":"14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2017.06.020","article-title":"The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH\/Siah1 in a CB2-receptor dependent manner.","volume":"167","author":"Liu","year":"2017","journal-title":"Brain Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1179\/016164110X12556180206112","article-title":"PPAR\u03b3 agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.","volume":"3","author":"Tang","year":"2010","journal-title":"Neurol Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1039\/C2CS35065C","article-title":"Nanomaterials design and tests for neural tissue engineering.","volume":"4","author":"Gelain","year":"2013","journal-title":"Chem Soc Rev"},{"key":"17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/nnm.09.93","article-title":"Nanotechnology for treatment of stroke and spinal cord injury.","volume":"5","author":"Sykov\u00e1","year":"2010","journal-title":"Nanomedicine (Lond)"},{"key":"18","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/smll.200800838","article-title":"Repairing the damaged spinal cord and brain with nanomedicine.","volume":"4","author":"Ivanisevic","year":"2008","journal-title":"Small"},{"key":"19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","article-title":"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.","volume":"32","author":"Piepmeier","year":"1990","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/BRS.0b013e3181b613c7","article-title":"Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications.","volume":"3","author":"Tanaka","year":"2009","journal-title":"Spine"},{"key":"21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.npep.2015.06.004","article-title":"Effect of carnosine, methylprednisolone and their combined application on irisin levels in the plasma and brain of rats with acute spinal cord injury.","volume":"5","author":"Aydin","year":"2015","journal-title":"Neuropeptides"},{"key":"22","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1097\/01.brs.0000250273.28483.5c","article-title":"Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center.","volume":"3","author":"Takagishi","year":"2006","journal-title":"Spine"},{"key":"23","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1016\/j.biomaterials.2008.12.077","article-title":"Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury.","volume":"3","author":"Bellamkonda","year":"2009","journal-title":"Biomaterials"},{"key":"24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/00006123-200112000-00022","article-title":"Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury.","volume":"4","author":"Young","year":"2001","journal-title":"Neurosurgery"},{"key":"25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.sc.3101681","article-title":"High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients.","volume":"4","author":"Sipski","year":"2005","journal-title":"Spinal Cord"},{"key":"26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3109\/10837450.2016.1143002","article-title":"Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model.","volume":"2","author":"Oner","year":"2017","journal-title":"Pharm Dev Technol"},{"key":"27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.expneurol.2011.09.028","article-title":"Polymer and nano-technology applications for repair and reconstruction of the central nervous system.","volume":"23","author":"Borgens","year":"2012","journal-title":"Exp Neurol"},{"key":"28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00006123-200209000-00024","article-title":"Biodegradable polymer grafts for surgical repair of the injured spinal cord.","volume":"5","author":"Yaszemski","year":"2002","journal-title":"Neurosurgery"},{"key":"29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4103\/1673-5374.228756","article-title":"Efficacy of chitosan and sodium alginate scaffolds for repair of spinal cord injury in rats.","volume":"1","author":"Wu","year":"2018","journal-title":"Neural Regen Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fncel.2014.00337","article-title":"Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats.","volume":"8","author":"Bassiouny","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphotobiol.2018.11.016","article-title":"Synthesis of cerium oxide nanoparticles loaded on chitosan for enhanced auto-catalytic regenerative ability and biocompatibility for the spinal cord injury repair.","volume":"19","author":"Song","year":"2019","journal-title":"J Photochem Photobiol B"},{"key":"32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12951-017-0272-7","article-title":"Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury.","volume":"1","author":"Li","year":"2017","journal-title":"J Nanobiotechnology"},{"key":"33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/glia.22904","article-title":"Mechanism of microglia neuroprotection: involvement of P2X7, TNF\u03b1, and valproic acid.","volume":"6","author":"Biber","year":"2016","journal-title":"Glia"},{"key":"34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","article-title":"Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3.","volume":"1","author":"Li","year":"2018","journal-title":"J Neuroinflammation"},{"key":"35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1179\/1743132814Y.0000000438","article-title":"Systemic administration of valproic acid stimulates overexpression of microtubule-associated protein 2 in the spinal cord injury model to promote neurite outgrowth.","volume":"3","author":"Noori-Zadeh","year":"2015","journal-title":"Neurol Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1471-4159.2012.07731.x","article-title":"Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.","volume":"12","author":"Yune","year":"2012","journal-title":"J Neurochem"},{"key":"37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.","volume":"8","author":"Li","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.brainres.2011.03.040","article-title":"Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.","volume":"139","author":"Dong","year":"2011","journal-title":"Brain Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuroscience.2011.01.012","article-title":"Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury.","volume":"17","author":"Casas","year":"2011","journal-title":"Neuroscience"},{"key":"40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jnr.22309","article-title":"Functional silica nanoparticle-mediated neuronal membrane sealing following traumatic spinal cord injury.","volume":"8","author":"Borgens","year":"2010","journal-title":"J Neurosci Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nnano.2014.312","article-title":"Erratum: squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury.","volume":"1","author":"Tagit","year":"2015","journal-title":"Nat Nanotechnol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.ijbiomac.2017.08.057","article-title":"Size optimization and in vitro biocompatibility studies of chitosan nanoparticles.","volume":"10","author":"Sukumaran","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1754-1611-4-2","article-title":"Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury.","volume":"4","author":"Ben Borgens","year":"2010","journal-title":"J Biol Eng"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:23:24Z","timestamp":1599078204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,31]]}},"alternative-id":["103125","32463791"],"URL":"https:\/\/doi.org\/10.18632\/aging.103125","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]}}}